Literature DB >> 12112248

Symbolic discriminant analysis of microarray data in autoimmune disease.

Jason H Moore1, Joel S Parker, Nancy J Olsen, Thomas M Aune.   

Abstract

New laboratory technologies such as DNA microarrays have made it possible to measure the expression levels of thousands of genes simultaneously in a particular cell or tissue. The challenge for genetic epidemiologists will be to develop statistical and computational methods that are able to identify subsets of gene expression variables that classify and predict clinical endpoints. Linear discriminant analysis is a popular multivariate statistical approach for classification of observations into groups. This is because the theory is well described and the method is easy to implement and interpret. However, an important limitation is that linear discriminant functions need to be prespecified. To address this limitation and the limitation of linearity, we have developed symbolic discriminant analysis (SDA) for the automatic selection of gene expression variables and discriminant functions that can take any form. In the present study, we demonstrate that SDA is capable of identifying combinations of gene expression variables that are able to classify and predict autoimmune diseases. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112248     DOI: 10.1002/gepi.1117

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  15 in total

1.  Genes and autoimmune diseases - a complex inheritance.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-12-08

2.  Mask Functions for the Symbolic Modeling of Epistasis Using Genetic Programming.

Authors:  Ryan J Urbanowicz; Bill C White; Jason H Moore
Journal:  Genet Evol Comput Conf       Date:  2008-07-12

3.  Genetic Programming Neural Networks: A Powerful Bioinformatics Tool for Human Genetics.

Authors:  Marylyn D Ritchie; Alison A Motsinger; William S Bush; Christopher S Coffey; Jason H Moore
Journal:  Appl Soft Comput       Date:  2007-01       Impact factor: 6.725

4.  Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies.

Authors:  Emily R Holzinger; Marylyn D Ritchie
Journal:  Pharmacogenomics       Date:  2012-01       Impact factor: 2.533

5.  ATHENA: A knowledge-based hybrid backpropagation-grammatical evolution neural network algorithm for discovering epistasis among quantitative trait Loci.

Authors:  Stephen D Turner; Scott M Dudek; Marylyn D Ritchie
Journal:  BioData Min       Date:  2010-09-27       Impact factor: 2.522

6.  Assessment and modeling of routinely used biochemical laboratory data of healthy individuals and end-stage renal failure (ESRF) patients by three different chemometric methods.

Authors:  Agelos Papaioannou; George Rigas; Panagiotis Plageras; George A Karikas; George Karamanis
Journal:  J Clin Lab Anal       Date:  2013-05       Impact factor: 2.352

7.  Feature selection and molecular classification of cancer using genetic programming.

Authors:  Jianjun Yu; Jindan Yu; Arpit A Almal; Saravana M Dhanasekaran; Debashis Ghosh; William P Worzel; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

8.  Grammatical evolution decision trees for detecting gene-gene interactions.

Authors:  Alison A Motsinger-Reif; Sushamna Deodhar; Stacey J Winham; Nicholas E Hardison
Journal:  BioData Min       Date:  2010-11-18       Impact factor: 2.522

9.  Using rule-based machine learning for candidate disease gene prioritization and sample classification of cancer gene expression data.

Authors:  Enrico Glaab; Jaume Bacardit; Jonathan M Garibaldi; Natalio Krasnogor
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

10.  GPNN: power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease.

Authors:  Alison A Motsinger; Stephen L Lee; George Mellick; Marylyn D Ritchie
Journal:  BMC Bioinformatics       Date:  2006-01-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.